Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin‐1β

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Fundamental & Clinical Pharmacology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1472-8206.2004.00228.xPMID 15066132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• P-450 metabolites of arachidonic acid in the control of cardiovascular function.

  2002cited by this paper
• [Regulation of cytochrome P-450 (CYP) genes by nuclear receptors].

  2002cited by this paper
• Noninvasive measurement of hydrogen and potassium ion flux from single cells and epithelial structures.

  2001cited by this paper
• The lung HETEs (and EETs) up.

  2001cited by this paper
• Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension

  2001cited by this paper
• Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

  2000cited by this paper
• Biochemical and molecular characteristics of the cytochrome P450 arachidonic acid monooxygenase.

  2000cited by this paper
• Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase.

  2000cited by this paper
• Airway synthesis of 20-hydroxyeicosatetraenoic acid: metabolism by cyclooxygenase to a bronchodilator.

  1999cited by this paper
• Renal effects of cP450 arachidonate metabolites in the Lyon hypertensive rat

  1999cited by this paper
• Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.

  1999cited by this paper
• Tissue sources of cytochrome P450 4A and 20-HETE synthesis in rabbit lungs.

  1998cited by this paper
• Peroxisome proliferator-activated receptor agonists.

  1997cited by this paper
• A novel murine P-450 gene , Cyp 4 a 14 , is part of a cluster of Cyp 4 a and Cyp 4 b , but not of CYP 4 F , genes in mouse and humans

  1997cited by this paper
• Peroxisome proliferator activated receptor agonists.

  1997cited by this paper
• Regulation of cytochromes P450 during inflammation and infection.

  1997cited by this paper
• The cytochrome P450 4 (CYP4) family.

  1997cited by this paper
• Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue.

  1997cited by this paper
• A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans.

  1997cited by this paper
• P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

  1996cited by this paper
• Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.

  1996cited by this paper
• Interleukin-1 beta antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture.

  1995cited by this paper
• Interleukin‐1β antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture

  1995cited by this paper
• The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance.

  1995cited by this paper
• Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs.

  1993cited by this paper
• Induction of cytochrome P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro.

  1993cited by this paper
• Repression of cytochrome P450 by cytokines: IL-1β counteracts clofibric acid induction of CYP4A in cultured fetal rat hepatocytes

  1993cited by this paper
• Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.

  1993cited by this paper
• Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone.

  1992cited by this paper
• Suppressive effect of interleukin-1 on pulmonary cytochrome P450 and superoxide anion production.

  1992cited by this paper
• Formation of 20-hydroxyprostaglandins by lungs of pregnant rabbits.

  1978cited by this paper
• Abbreviated title: Localization of CYP4A in rat lung Corresponding Author:

  year unknowncited by this paper

• The Central Role of Cytochrome P450 Reductase (CPR) in Hyperoxic Lung Injury

  2025cites this paper
• Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice

  2023cites this paper
• Target RNA expression omics approach to reveal the liver detoxification effect induced by Chinese medicine prescription Niu Huang Jie Du against realgar overexposure to mice.

  2022cites this paper
• Uncommon side effects of common drugs in patients with familial dysautonomia

  2021cites this paper
• The role of cytochrome P450 (CYP) enzymes in hyperoxic lung injury

  2020cites this paper
• Isolation and cultivation of metabolically competent alveolar epithelial cells from A/J mice.

  2014cites this paper
• Regulation of Drug Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

  2012cites this paper
• 20-HETE Mediates Ozone-Induced, Neutrophil-Independent Airway Hyper-Responsiveness in Mice

  2010cites this paper
• Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human P450 enzymes.

  2009cites this paper
• Nuclear Receptors and Inflammatory Diseases

  2008cites this paper
• Clofibrate and dalargin increase luminol-dependent chemiluminescence of mouse blood

  2007cites this paper
• In vitro screening of 200 pesticides for agonistic activity via mouse peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma and quantitative analysis of in vivo induction pathway.

  2006cites this paper
• Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases?

  2006cites this paper